Nautilus Biotechnology, Inc.

NASDAQ:NAUT

Biotechnology

Healthcare
$2.43 +2.06%

+$0.05 today

Market cap
$309.51M
Beta
0.75
P/E (TTM)
-4.9
EPS (TTM)
-$0.45
52W Low $0.62High $4.31

Volume 4.55M

Average 0.40M

Balance Sheet

Inspect the capital base behind the business.

Assets

$191.11M

FY 2025 · Annual

-21.3% YoY

Liabilities

$34.14M

FY 2025 · Annual

+0.4% YoY

Equity

$156.97M

FY 2025 · Annual

-24.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents185.62M114.52M19.4M27.65M12.39M
Short-term Investments160.11M69.95M154.02M102.25M91.02M
Net Receivables00000
Inventory00000
Other Current Assets003.42M2.93M2.56M
Total Current Assets349.22M187.21M176.84M132.83M105.96M
Property, Plant & Equipment (Net)31.86M32.57M36.9M32.33M31.23M
Goodwill00000
Intangible Assets00000
Long-term Investments16.37M129.17M90.65M76.41M52.74M
Tax Assets00000
Other Non-current Assets997K1.11M1.18M1.18M1.18M
Total Non-current Assets49.23M162.84M128.73M109.92M85.15M
Total Assets398.45M350.05M305.57M242.74M191.11M
Account Payables1.72M1.27M1.64M987K943K
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities388K438K2.97M1.86M2.7M
Total Current Liabilities5.81M6.79M9.12M7.63M7.95M
Long-term Debt000026.19M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities29.06M28.34M31.09M26.38M26.19M
Total Liabilities34.87M35.13M40.21M34.01M34.14M
Common Stock12K12K13K13K13K
Retained Earnings(80.64M)(138.56M)(202.24M)(273.02M)(332.02M)
Accumulated OCI(184K)(1.85M)(255K)57K243K
Other Stockholders Equity(0)0000
Minority Interest00000
Total Equity363.58M314.92M265.35M208.73M156.97M
Total Debt30.03M30.33M34.63M30.48M30.02M
Net Debt(155.59M)(84.2M)15.23M2.83M17.63M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$14.6M
Short-term Investments$81.2M
Other Current$3.0M
Total Current Assets$98.8M
PP&E (Net)$30.3M
Long-term Investments$47.5M
Other Non-current$1.2M
Total Non-current Assets$78.9M
Total Assets$177.8M

Analysis

Selected assets total $177.8M for Latest. The largest visible component is Short-term Investments at $81.2M, about 45.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13D/ASC 13D/A filingNov 3, 2026
10-QQuarterly reportOct 27, 2026
8-KCurrent reportOct 27, 2026
EFFECTEFFECT filingSep 18, 2026
424B5424B5 filingSep 18, 2026

How much cash does NAUT have?

Nautilus Biotechnology, Inc. (NAUT) reported $12.39M in cash and equivalents in fiscal 2025.

How much debt does NAUT carry?

Nautilus Biotechnology, Inc. (NAUT) reported $30.02M of total debt, with net debt of $17.63M.